Status:
ACTIVE_NOT_RECRUITING
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
Lead Sponsor:
Thomas Jefferson University
Conditions:
Prostate Carcinoma
Eligibility:
All Genders
Brief Summary
This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetic...
Detailed Description
PRIMARY OBJECTIVE: I. To assess perceived usefulness of a virtual genetics board. SECONDARY OBJECTIVE: I. To assess acceptability/feasibility, perceived ease of use, self-efficacy for recommendatio...
Eligibility Criteria
Inclusion
- Individuals must meet one of the following inclusion criteria in order to be eligible to participate in the study:
- Healthcare providers (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers) who evaluate, manage, or treat men with prostate cancer or screen men for prostate cancer.
- Providers who perform prostate cancer genetic testing for men (genetic counselors or healthcare providers)
- Scientists and researchers
- Advocacy or patient stakeholder organization members
Exclusion
- • Non-medical providers
Key Trial Info
Start Date :
January 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 24 2026
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT04789018
Start Date
January 21 2020
End Date
June 24 2026
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107